Post-Market Respiratory Study
Visits reduced 12 → 2. Diary completion > 95%. Retention: 94%.
Overall compliance
92.0%
+5.2% vs goal
Diary completion (90 days)
95.0%
2–3× vs baseline
Delve Concierge
📞 Phone
💬 Chat
👤 Human support
Online · 65+ languages
I missed today’s diary and I’m not sure what to do.
No problem — I can walk you through it now. It only takes about 2 minutes.
I’ve also checked your device for you — everything is syncing correctly.
Coordinator online
Watching tasks in real time
0
Studies Supported
0
Countries
0
Participants
0
Max eCOA Completion
Outcomes that matter
Retention & compliance at scale.
- Reduce dropouts with proactive, human-led follow-up and real-time alerts.
- Increase compliance with multilingual support and personalized patient journeys.
- Run hybrid and decentralized trials without adding vendors or complexity.
- Access real-time data and analytics to make faster, better-informed decisions.
Patient Retention Over Time
Delve Health vs. industry average
Month 198% · 95%
Month 394% · 85%
Month 690% · 75%
Month 1287% · 65%
Delve Health
Industry Avg
Trusted by leading pharma, biotech, and medtech teams
Pfizer
Novartis
Johnson & Johnson
Roche
Merck
AstraZeneca
Human-driven clinical trial
Concierge-as-a-Service™
Technology can remind. Humans get results. Delve’s concierges watch study activity in real time and step in the moment a participant drifts—protecting compliance before it becomes a deviation or a dropout.
They also pre-screen referrals, guide patients through structured questions, confirm interest, and deliver only qualified candidates to sites.
- Proactive compliance: Real-time monitoring and fast human follow-up.
- Pre-screening: Calling referrals and qualifying only eligible, interested patients.
- Multilingual support: Empathetic outreach in 65+ languages.
- Site relief: We handle reminders, rescheduling, and participant questions.
The result: higher completion, fewer dropouts, and calmer, more predictable studies.
Learn More
One Platform. Four Pillars.
Delve wraps compliance and retention around an integrated digital platform — combining eCOA, digital measures, consent, and analytics with a human layer that keeps everything moving.
eCOA & ePRO
Accessible, multilingual diaries and outcomes that patients can actually complete.
Digital Measures
Validated, fit-for-purpose measures from wearables and sensors, ready for regulators.
Concierge-as-a-Service™
Human teams who own the work of keeping participants active, informed, and on schedule.
Compliance Analytics
Real-time dashboards that surface risk early and prove the health of your trial.
Who We Serve
Whether you're developing a drug, launching a device, or leading a site network, Delve Health surrounds your study with the compliance and retention support it needs to finish strong.
Pharma
Protect pivotal endpoints with high diary completion and retention.
MedTech
Support post-market and real-world studies with engaged participants.
Biotech
Give lean teams an experienced compliance partner from day one.
Research Sites
Offload reminders, calls, and rescheduling so staff can focus on care.
What Changes When Delve Runs Compliance
| Without Delve | With Delve |
|---|---|
| Coordinators chasing diaries and visits manually. | Concierge team owns reminders, follow-up, and rescheduling. |
| Late discovery of at-risk participants. | Real-time dashboards and alerts with human outreach in minutes. |
| Inconsistent onboarding across sites and countries. | Standardized, multilingual onboarding for every participant and caregiver. |
| Surprise dropouts before key endpoints. | Early intervention and coaching to keep participants engaged. |
Proven in Global Studies
Hybrid Oncology Program
63% increase in retention after layering in concierge support.
Digital Endpoint Enablement
35% increase in usable data within the first 14 days.
View Case Studies
Testimonials
Trusted by clinical operations leaders.
“
Delve Health cut our dropout rate by nearly 40% compared to previous trials. Their real-time engagement and concierge team changed how our coordinators work.
Dr. Sarah Mitchell
Director of Clinical Operations, Global Biotech Sponsor
“
With Delve, we finally had one place to see compliance, retention, and risk. We completed enrollment three months early with cleaner data at database lock.
James Chen
VP, Clinical Development, Mid-size Pharma
“
One vendor instead of five simplified our operations dramatically. The concierge services alone were worth the investment.
Maria Rodriguez
Clinical Trial Manager, Leading CRO
Ready to Make Compliance Your Advantage?
Bring Delve into your next protocol as the compliance and retention layer — so your team can focus on the science, not the chasing.
Talk About Your Study